Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2016 Oct;196(4):989-99.
doi: 10.1016/j.juro.2016.04.081. Epub 2016 May 6.

Management of Renal Masses and Localized Renal Cancer: Systematic Review and Meta-Analysis

Affiliations
Meta-Analysis

Management of Renal Masses and Localized Renal Cancer: Systematic Review and Meta-Analysis

Phillip M Pierorazio et al. J Urol. 2016 Oct.

Abstract

Purpose: Several options exist for management of clinically localized renal masses suspicious for cancer, including active surveillance, thermal ablation and radical or partial nephrectomy. We summarize evidence on effectiveness and comparative effectiveness of these treatment approaches for patients with a renal mass suspicious for localized renal cell carcinoma.

Materials and methods: We searched MEDLINE®, Embase® and the Cochrane Central Register of Controlled Trials from January 1, 1997 through May 1, 2015. Paired investigators independently screened articles to identify controlled studies of management options or cohort studies of active surveillance, abstracted data sequentially and assessed risk of bias independently. Strength of evidence was graded by comparisons.

Results: The search identified 107 studies (majority T1, no active surveillance or thermal ablation stratified outcomes of T2 tumors). Cancer specific survival was excellent among all management strategies (median 5-year survival 95%). Local recurrence-free survival was inferior for thermal ablation with 1 treatment but reached equivalence to other modalities after multiple treatments. Overall survival rates were similar among management strategies and varied with age and comorbidity. End-stage renal disease rates were low for all strategies (0.4% to 2.8%). Radical nephrectomy was associated with the largest decrease in estimated glomerular filtration rate and highest incidence of chronic kidney disease. Thermal ablation offered the most favorable perioperative outcomes. Partial nephrectomy showed the highest rates of urological complications but overall rates of minor/major complications were similar among interventions. Strength of evidence was moderate, low and insufficient for 11, 22 and 30 domains, respectively.

Conclusions: Comparative studies demonstrated similar cancer specific survival across management strategies, with some differences in renal functional outcomes, perioperative outcomes and postoperative harms that should be considered when choosing a management strategy.

Keywords: carcinoma, renal cell; comparative effectiveness research; disease management; kidney neoplasms; surgical procedures, operative.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Summary of literature search
Figure 2
Figure 2
Notable meta-analyses on effectiveness of radical vs partial nephrectomy, radical nephrectomy vs thermal ablation and partial nephrectomy vs thermal ablation. Effect size is given as relative risk for cancer specific survival and overall survival, and odds ratios for other outcomes. CKD, chronic kidney disease. sec., secondary. TA, thermal ablation.

Comment in

  • Editorial Comment.
    Campbell SC. Campbell SC. J Urol. 2016 Oct;196(4):999. doi: 10.1016/j.juro.2016.04.103. Epub 2016 Jun 28. J Urol. 2016. PMID: 27368141 No abstract available.
  • Editorial Comment.
    Dahm P. Dahm P. J Urol. 2016 Oct;196(4):998. doi: 10.1016/j.juro.2016.04.102. Epub 2016 Jun 28. J Urol. 2016. PMID: 27368142 No abstract available.

References

    1. Kutikov A, Fossett LK, Ramchandani P, et al. Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology. 2006;68:737. - PubMed
    1. Thompson RH, Hill JR, Babayev Y, et al. Metastatic renal cell carcinoma risk according to tumor size. J Urol. 2009;182:41. - PMC - PubMed
    1. Lane BR, Babineau D, Kattan MW, et al. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy. J Urol. 2007;178:429. - PubMed
    1. American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society 2014; Available at http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2.... Accessed September 24, 2014.
    1. Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management of the clinical T1 renal mass. J Urol. 2009;182:1271. - PubMed